EI
PBYI icon

Ellevest Inc’s Puma Biotechnology PBYI Stock Holding History

Ellevest Inc’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-94
Closed – – 1790
2022
Q2 		$0 Buy
+94
New +$234 ﹤0.01% 1609

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Ellevest Inc's PBYI Position: Q3 2022 in Review

Ellevest Inc sold out of Puma Biotechnology (PBYI) in Q3 2022, closing a stake of 94 shares.

Ellevest Inc first reported a position in PBYI in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 83 funds tracked by Wall St. Rank hold PBYI as of Q3 2022.

  • Ellevest Inc reported no remaining Puma Biotechnology position as of Q3 2022 after selling out during the quarter.
  • Ellevest Inc sold 94 Puma Biotechnology shares in Q3 2022.
  • Ellevest Inc first reported a position in Puma Biotechnology in Q2 2022 and held it in 1 quarter.
  • Ellevest Inc's Puma Biotechnology position peaked at $0 in Q2 2022.
  • 83 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.